M 1818 2'-(O-Methyl)-5-iodouridine |
|
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
Solid | |
Screw cap v-vial | Please Inquire for Pricing |
M.W. 384.12 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
M 1815 2'-(O-Methyl)uridine |
|
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
Solid | |
Screw cap v-vial | 1 mg $215 |
M.W. 258.23 | 5 mg $565 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 2623 2'-O-Methyluridine, [4-14C]- |
|
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
Solid | |
> 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
NextGen V-Vial - shipped on dry ice | |
M.W. 258.23 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 2771 (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine, [14C]- |
|
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
Solid | |
≥ 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
NextGen V-Vial - shipped on dry ice | |
M.W. 260.22 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 1836 2'-(O-Methyl)uridine, [3H]- |
|
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
Ethanol:water (1:1) solution, 1 mCi/ml | |
> 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
NextGen V-Vial - shipped on dry ice | |
M.W. 258.23 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
M 1744 3'-(O-Methyl)uridine |
|
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
Solid | |
Screw cap v-vial | Please Inquire for Pricing |
M.W. 258.23 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 1795 3'-(O-Methyl)uridine, [3H]- |
|
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
Ethanol:water (1:1) solution, 1 mCi/ml | |
> 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
NextGen V-Vial - shipped on dry ice | |
M.W. 258.23 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
M 1804 N3-Methyluridine |
|
Click here for Typical Certificate of Analysis | |
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
Solid | |
Screw cap v-vial | 1 mg $215 |
M.W. 258.23 | 5 mg $565 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 1827 N3-Methyluridine, [3H]- |
|
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
Ethanol:water (1:1) solution, 1 mCi/ml | |
> 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
NextGen V-Vial - shipped on dry ice | |
M.W. 258.23 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |